Report #2868942

Received Oct 28, 2025

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 23 yrs
State: MS
Recovered: Not recovered
Vaccinated: Oct 23, 2024
Onset: Jan 1, 2025
Days to onset: 70
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	—	IM / RA

Symptoms (13)

Anti-cyclic citrullinated peptide antibodyAntinuclear antibodyBlood immunoglobulin ABlood immunoglobulin GBlood uric acidC-reactive proteinCyanosisHypoaesthesiaParaesthesiaProcalcitoninRaynaud's phenomenonRed blood cell sedimentation rateRheumatoid factor

Symptom narrative

Within approximately 3 months of the vaccination, symptoms of Raynaud's Syndrome (also known as Raynaud's Phenomenon or Raynaud's Disease) began to appear. These symptoms included phalanges, particularly toes, that would become numb and turn white, then cyanotic, then return to normal pink color at random over a period of 5-10 mins. A sensation of tingling or pins and needles could be felt during these occurrences. These occurrences happened frequently (almost daily, sometimes multiple times per day.) These occurrences would happen at random, such as on the beach, driving, walking, running. These occurrences would happen even when extra measures (thick socks, warm environment) were in place to prevent symptoms.

Current illness

HPV diagnosis

Medical history

None

Other medications

None

Allergies

None

Lab data

CRP, ANA, ESR, Procalcitonin, uric acid, rheumatoid factor, anti-CCP AB IgG/IgA (July 2025), ANA profile (September 2025)